| scholarly article | Q13442814 |
| P50 | author | Anne B. Newman | Q21401975 |
| Stephen B Kritchevsky | Q40122833 | ||
| Tamara B. Harris | Q63213673 | ||
| Suzanne Satterfield | Q67379283 | ||
| Michael G Shlipak | Q87224063 | ||
| Glenn Chertow | Q87653339 | ||
| Steven R Cummings | Q92996256 | ||
| Frances A Tylavsky | Q114293436 | ||
| Christina L Wassel Fyr | Q114407552 | ||
| P2093 | author name string | Linda F Fried | |
| P433 | issue | 1 | |
| P304 | page(s) | 254-261 | |
| P577 | publication date | 2005-11-02 | |
| P1433 | published in | Journal of the American Society of Nephrology | Q17123893 |
| P1476 | title | Cystatin C and mortality risk in the elderly: the health, aging, and body composition study | |
| P478 | volume | 17 |
| Q35916160 | A New Equation to Estimate Muscle Mass from Creatinine and Cystatin C |
| Q41130107 | A comparison of RIFLE, AKIN, KDIGO, and Cys-C criteria for the definition of acute kidney injury in critically ill patients |
| Q57167377 | A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup |
| Q21261435 | A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study |
| Q46495930 | Association between markers of renal function and C-reactive protein level in the elderly: confounding by functional status |
| Q36423854 | Association of Serum Erythropoietin With Cardiovascular Events, Kidney Function Decline, and Mortality: The Health Aging and Body Composition Study |
| Q36796208 | Association of a Modified Physiologic Index with mortality and incident disability: the Health, Aging, and Body Composition study |
| Q33932292 | Association of cystatin C with adverse outcomes. |
| Q24646339 | Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study |
| Q36667225 | Association of mild to moderate kidney dysfunction and coronary calcification |
| Q46085186 | Association of serum albumin levels with kidney function decline and incident chronic kidney disease in elders. |
| Q50995420 | Associations between biomarkers of renal function with cerebral microbleeds in hypertensive patients. |
| Q34150807 | Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study |
| Q38079565 | Biomarkers in atrial fibrillation: a clinical review |
| Q37323794 | Biomarkers related to aging in human populations. |
| Q51725868 | Blood Selenium Concentration and Blood Cystatin C Concentration in a Randomly Selected Population of Healthy Children Environmentally Exposed to Lead and Cadmium. |
| Q36638809 | Combined association of albuminuria and cystatin C-based estimated GFR with mortality, coronary heart disease, and heart failure outcomes: the Atherosclerosis Risk in Communities (ARIC) Study |
| Q36652786 | Combined association of creatinine, albuminuria, and cystatin C with all-cause mortality and cardiovascular and kidney outcomes |
| Q33608612 | Comparison of CKD-EPI Cystatin C and Creatinine Glomerular Filtration Rate Estimation Equations in Asian Indians |
| Q34267914 | Comparison of estimated glomerular filtration rate by the chronic kidney disease epidemiology collaboration (CKD-EPI) equations with and without Cystatin C for predicting clinical outcomes in elderly women |
| Q92658895 | Creatinine versus cystatin C for renal function-based mortality prediction in an elderly cohort: The Northern Manhattan Study |
| Q35658295 | Cystatin C Is Not Causally Related to Coronary Artery Disease |
| Q84602658 | Cystatin C and NT-proBNP as prognostic biomarkers in Fabry disease |
| Q36027716 | Cystatin C and Risk of Diabetes and the Metabolic Syndrome - Biomarker and Genotype Association Analyses |
| Q34959486 | Cystatin C and albuminuria as risk factors for development of CKD stage 3: the Multi-Ethnic Study of Atherosclerosis (MESA) |
| Q43180532 | Cystatin C and cardiac hypertrophy in primary hypertension. |
| Q48290752 | Cystatin C as a Marker of Progressing Cardiovascular Events during Coronary Heart Disease |
| Q48433405 | Cystatin C as an index of cerebral small vessel disease: results of a cross-sectional study in community-based Japanese elderly |
| Q37181967 | Cystatin C associates with arterial stiffness in older adults |
| Q51621252 | Cystatin C estimated renal dysfunction predicts T wave axis deviation in US adults: results from NHANES III. |
| Q35746107 | Cystatin C is associated with inflammation but not atherosclerosis in systemic lupus erythematosus |
| Q24635177 | Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study |
| Q35189962 | Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons |
| Q42803609 | Cystatin C, creatinine, and albuminuria: bringing risk into 3 dimensions |
| Q37660880 | Cystatin C- and creatinine-based estimated glomerular filtration rate, vascular disease, and mortality in persons with diabetes in the U.S. |
| Q37856794 | Cystatin C: a step forward in assessing kidney function and cardiovascular risk |
| Q37313436 | Cystatin C: current position and future prospects |
| Q34274728 | Data mining identifies Digit Symbol Substitution Test score and serum cystatin C as dominant predictors of mortality in older men and women |
| Q37331226 | Diabetes and risk of hospitalized fall injury among older adults |
| Q27009523 | Epidemiology, clinical characteristics, and management of chronic kidney disease in human immunodeficiency virus-infected patients |
| Q35819414 | Estimating glomerular filtration rate in kidney transplantation: Still searching for the best marker |
| Q35950332 | Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: a kidney-heart connection |
| Q34262418 | Fat infiltration of muscle, diabetes, and clinical fracture risk in older adults |
| Q36095111 | Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study). |
| Q35715869 | Filtration markers may have prognostic value independent of glomerular filtration rate |
| Q37065589 | GFR estimating equations: getting closer to the truth? |
| Q37051743 | HIV viremia and changes in kidney function |
| Q22306345 | Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association |
| Q22306356 | Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association |
| Q22241921 | Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association |
| Q30238784 | Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association |
| Q29547236 | Heart disease and stroke statistics--2011 update: a report from the American Heart Association |
| Q29547909 | Heart disease and stroke statistics--2012 update: a report from the American Heart Association |
| Q29547691 | Heart disease and stroke statistics--2014 update: a report from the American Heart Association |
| Q35032801 | Higher cystatin C level predicts long-term mortality in patients with peripheral arterial disease. |
| Q34361219 | Higher levels of cystatin C are associated with worse cognitive function in older adults with chronic kidney disease: the chronic renal insufficiency cohort cognitive study |
| Q37980388 | How to manage HIV-infected patients with chronic kidney disease in the HAART era. |
| Q46783054 | Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study |
| Q37518114 | Kidney function and mortality in octogenarians: Cardiovascular Health Study All Stars |
| Q33804430 | Kidney function and multiple hemostatic markers: cross sectional associations in the multi-ethnic study of atherosclerosis |
| Q64997778 | Long-term exposure to ambient air pollution and renal function in African Americans: the Jackson Heart Study. |
| Q57497992 | Low blood pressure levels for fall injuries in older adults: the Health, Aging and Body Composition Study |
| Q34629623 | Metabolic abnormalities are present in adults with elevated serum cystatin C |
| Q38774796 | Metabolites Associated With Lean Mass and Adiposity in Older Black Men. |
| Q37367733 | Method of glomerular filtration rate estimation affects prediction of mortality risk |
| Q38864815 | Novel biomarkers with potential for cardiovascular risk reclassification |
| Q38669818 | Predicting acute kidney injury: current status and future challenges |
| Q33591588 | Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC). |
| Q59049724 | Preinterventional Cystatin C: A Highly Prognostic Marker for All-Cause Mortality after Coronarography |
| Q37157282 | Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation |
| Q34021375 | Prevalence of kidney disease in anaemia differs by GFR-estimating method: the Third National Health and Nutrition Examination Survey (1988-94). |
| Q35828786 | Racial variation in the relationship of anemia with mortality and mobility disability among older adults |
| Q33646576 | Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C. |
| Q34572458 | Recent developments in HIV-related kidney disease |
| Q37287645 | Reduced renal function and sleep-disordered breathing in community-dwelling elderly men. |
| Q35652795 | Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s |
| Q34978336 | Relationship between Systemic and Cerebral Vascular Disease and Brain Structure Integrity in Normal Elderly Individuals |
| Q33905277 | Relationship between cystatin C and coronary artery atherosclerosis progression differs by type 1 diabetes |
| Q37615466 | Relationship between serum cystatin C and polycystic ovary syndrome |
| Q37089078 | Renal dysfunction in burns: a review |
| Q36984850 | Renal function and sleep-disordered breathing in older men. |
| Q37728876 | Rhein lysinate increases the median survival time of SAMP10 mice: protective role in the kidney |
| Q37870921 | Risk stratification and short-term prognosis in acute heart failure syndromes: a review of novel biomarkers |
| Q37190542 | Secreted klotho and chronic kidney disease |
| Q36418514 | Sensorimotor Peripheral Nerve Function and the Longitudinal Relationship With Endurance Walking in the Health, Aging and Body Composition Study |
| Q28390680 | Sensory and motor peripheral nerve function and longitudinal changes in quadriceps strength |
| Q33973496 | Sensory and motor peripheral nerve function and lower-extremity quadriceps strength: the health, aging and body composition study |
| Q37126608 | Serum creatinine and functional limitation in elderly persons |
| Q35508233 | Serum cystatin C - marker of inflammation and cardiovascular morbidity in chronic kidney disease stages 1-4 |
| Q36392738 | Serum cystatin C- versus creatinine-based definitions of acute kidney injury following cardiac surgery: a prospective cohort study |
| Q45973807 | Serum cystatin C: a useful marker of kidney function in very old people. |
| Q79314715 | Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease |
| Q35165510 | Systematic shifts in cystatin C between 2006 and 2010. |
| Q42772483 | The relationship of cystatin C, creatinine, estimated GFR, and cardiovascular events |
| Q38104269 | The use of biomarkers in the patient with heart failure |
| Q37045956 | Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates |
| Q34026824 | Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit. |
Search more.